DASHBOARD
This live dashboard displays figures and tables based on the data collected in the COPP study on invasive group A streptococcal disease in children (COPP-iGAS).
Information on the live scientific dashboard
The figures and tables are automatically generated from electronic case record files. Data control and monitoring is continuous. Data is automatically updated every day at 12:00 GMT+1. Patients without information about consent and/or period of hospital presentation are not included.
Data were retrospectively collected from 2015 to 2022, and prospectively since 2023. Patients included after 1-1-2022 were approached for informed consent on more detailed data collection.
Inclusion criteria for the COPP-iGAS study are:
- Age 0-17 years
- Presentation in Dutch hospital participating in our study
- Evidence of invasive Group A Streptoccocal Disease
Data from inclusion period with retrospective collection of limited data: 10
Hospitals.
Data from inclusion period with detailed data: 20
Hospitals
Realization: Adam Tulling & Erik von Asmuth
Data has last been updated on 2024-08-13 10:03:25 UTC
Figure 1. Children with Invasive Group A Streptococcal Disease per Year and Month
Figure 2. Map of Dutch Hospitals Participating in the COPP-iGAS Study
Epidemiological data of patients with invasive Group A streptococcal disease
Figure 1 A-B: All patients hospitalized between 2022-01-01 and 2023-12-31 are eligible to be included with detailed clinical data as part of the COPP-iGAS study. From 2015-01-01 up till 2021-12-31 patients are only included using deidentified data. C: The period of disease presentation were stratified based on the period before the COVID-19 pandemic (2015-2019), during (2020-2021), and the period after most COVID-19 restrictions were lifted (2022-2023).
Figure 2: Hospitals including patients by geographical location in the map of the Netherlands. For visualization purposes hospitals with lower numbers of inclusions were artificially inflated.
Table 1. General Cohort Characteristics
| Characteristic | Overall, N = 6341 | 2015-2019, N = 1981 | 2020-2021, N = 321 | 2022-2024, N = 4041 | Unknown, N = 01 |
|---|---|---|---|---|---|
| 1 n/N (%) | |||||
Table 2. Clinical Diagnoses per Age Category
General clinical data of patients with invasive Group A streptococcal disease
Table 1: The patients were classified into a clinical diagnostic group, which were chosen based on a hierarchical decision-making process. The classification process began with patients with pulmonary iGAS being placed in that group at the top of the table. The other diagnostic groups were then considered in descending order.
Table 2: Please note: Children can have more than one clinical syndrome caused by invasive group A streptococci in the course of a disease episode (for example pneumonia and bacteremia). Therefore, the total number of clinical syndromes is larger than the total number of children.